ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.906,08
-0,49%
S&P 500
5.942,47
1,26%
Dow Jones
42.732,13
0,80%
Euro vs US Dollar
1,03115
0,00%
Bitcoin
98.383,56
0,18%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Kanada
  5. TSX

  6. Fennec Pharmaceuticals Inc (FRX) Börsenkurse

Fennec Pharmaceuticals Inc

Fennec Pharmaceuticals Inc (FRX)

Flexiroam Limited
8,83
-0,24
(-2,65%)
Geschlossen 05 Januar 10:12PM
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
8,83
Gebot
8,76
Fragen
9,14
Volumen
1.450
8,81 Tagesbereich 9,01
5,65 52-Wochen-Bereich 15,20
Marktkapitalisierung
238,648M
Handelsende
9,07
Handelsbeginn
9,01
Letzte Trade
100
@
8.83
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
2.035
Ausgegebene Aktien
27.027.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-14,87
Gewinn pro Aktie (EPS)
-0,59
Erlöse
21,25M
Nettogewinn
-16,05M

Über Fennec Pharmaceuticals Inc

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Website
www.fennecpharma.com
Hauptsitz
Ottawa, Ontario, Can
Gegründet
-
Fennec Pharmaceuticals Inc is listed in the Biological Pds,ex Diagnstics sector of the Toronto Börse with ticker FRX. The last closing price for Fennec Pharmaceuticals was $9,07. Over the last year, Fennec Pharmaceuticals shares have traded in a share price range of $ 5,65 to $ 15,20.

Fennec Pharmaceuticals currently has 27.027.000 shares in issue. The market capitalisation of Fennec Pharmaceuticals is $245,13 million. Fennec Pharmaceuticals has a price to earnings ratio (PE ratio) of -14.87.

FRX Neueste Nachrichten

Weitere Nachrichten

Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales

~ PEDMARQSI® (anhydrous sodium thiosulfate) is the first and only treatment available within NHS England and Wales for the prevention of cisplatin-induced ototoxicity (hearing loss) in children...

20 Dezember 2024
GlobeNewswire Inc.

Fennec Pharmaceuticals Announces Early Partial Repayment of Its Outstanding Convertible Debt Facility with Petrichor Healthcare Capital Management

~ $13 Million Convertible Debt Repayment from Available Cash ~ ~ Elimination of Approximately $1.5 Million in Annual Interest Expense and Potential Equity Overhang of Approximately 1.6 Million...

19 Dezember 2024
GlobeNewswire Inc.

Fennec Pharmaceuticals to Participate in Upcoming Investor Conference

RESEARCH TRIANGLE PARK, N.C., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the...

12 Dezember 2024
GlobeNewswire Inc.

Fennec Pharmaceuticals to Participate in Upcoming Investor Conference

RESEARCH TRIANGLE PARK, N.C., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the...

13 November 2024
GlobeNewswire Inc.

Fennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

~ Achieved Third Quarter 2024 Net Product Sales of $7.0 Million ~ ~ Increasing Momentum and Successful Reimbursement in the Adolescent and Young Adult (AYA) Segment Following Strategic...

07 November 2024
GlobeNewswire Inc.

Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024

RESEARCH TRIANGLE PARK, N.C., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that...

31 Oktober 2024
GlobeNewswire Inc.

Fennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company’s Next Stage of Growth

~ Pierre S. Sayad, PhD, M.S., Appointed Chief Medical Officer ~ ~ Terry Evans Appointed Chief Commercial Officer ~ ~ Christiana Cioffi, MBA, Appointed Chief Strategy Officer ~ RESEARCH TRIANGLE...

28 Oktober 2024
GlobeNewswire Inc.

Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences

RESEARCH TRIANGLE PARK, N.C., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that...

05 September 2024
GlobeNewswire Inc.

Fennec Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update

~ Achieved Second Quarter 2024 Total Net Revenues of $7.3 Million ~ ~ Appointed Jeffrey S. Hackman as Chief Executive Officer (CEO) and Member of the Board of Directors ~ ~ Company Has...

13 August 2024
GlobeNewswire Inc.

Fennec Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 13, 2024

RESEARCH TRIANGLE PARK, N.C., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that...

06 August 2024
GlobeNewswire Inc.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.1-1.119820828678.939.388.815859.0112815CS
40.344.004711425218.499.38816188.69411061CS
123.0753.29861111115.769.385.6520357.56914827CS
260.536.385542168678.39.385.6518447.42282739CS
52-6.33-41.754617414215.1615.25.6513698.36788001CS
1563.2357.67857142865.615.435.358459.45735685CS
2600.465.495818399048.3715.434.9510179.21806902CS

FRX - Frequently Asked Questions (FAQ)

What is the current Fennec Pharmaceuticals share price?
The current share price of Fennec Pharmaceuticals is $ 8,83
How many Fennec Pharmaceuticals shares are in issue?
Fennec Pharmaceuticals has 27.027.000 shares in issue
What is the market cap of Fennec Pharmaceuticals?
The market capitalisation of Fennec Pharmaceuticals is CAD 245,13M
What is the 1 year trading range for Fennec Pharmaceuticals share price?
Fennec Pharmaceuticals has traded in the range of $ 5,65 to $ 15,20 during the past year
What is the PE ratio of Fennec Pharmaceuticals?
The price to earnings ratio of Fennec Pharmaceuticals is -14,87
What is the cash to sales ratio of Fennec Pharmaceuticals?
The cash to sales ratio of Fennec Pharmaceuticals is 11,23
What is the reporting currency for Fennec Pharmaceuticals?
Fennec Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Fennec Pharmaceuticals?
The latest annual turnover of Fennec Pharmaceuticals is USD 21,25M
What is the latest annual profit for Fennec Pharmaceuticals?
The latest annual profit of Fennec Pharmaceuticals is USD -16,05M
What is the registered address of Fennec Pharmaceuticals?
The registered address for Fennec Pharmaceuticals is C/O LABARGE WEINSTEIN LLP, 515 LEGGET DRIVE, SUITE 800, OTTAWA, ONTARIO, K2K 3G4
What is the Fennec Pharmaceuticals website address?
The website address for Fennec Pharmaceuticals is www.fennecpharma.com
Which industry sector does Fennec Pharmaceuticals operate in?
Fennec Pharmaceuticals operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
DIAMStar Diamond Corporation
$ 0,025
(25,00%)
17,1k
CSCICOSCIENS Biopharma Inc
$ 4,80
(22,14%)
11,2k
DII.BDorel Industries Inc
$ 4,88
(20,49%)
33,64k
ORVOrvana Minerals Corp
$ 0,28
(16,67%)
104,72k
YRBYorbeau Resources Inc
$ 0,04
(14,29%)
671k
FLNTFlint Corporation
$ 0,025
(-16,67%)
17k
RTGRTG Mining Inc
$ 0,03
(-14,29%)
544,49k
TWMTidewater Midstream and Infrastructure Ltd
$ 0,15
(-11,76%)
541,46k
EXROExro Technologies Inc
$ 0,13
(-10,34%)
676,19k
ASTLAlgoma Steel Group Inc
$ 12,92
(-7,58%)
196,97k
TDToronto Dominion Bank
$ 77,79
(1,69%)
17,95M
VRNVeren Inc
$ 7,48
(-1,32%)
6,26M
CNQCanadian Natural Resources Ltd
$ 45,61
(0,95%)
4,64M
ACAir Canada
$ 22,31
(-0,13%)
3,84M
BBBlackBerry Limited
$ 5,34
(-3,09%)
3,79M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

TSX
FRX
Fennec Pharmaceuticals
BOV
DIVO11
It Now Bovespa Fundo De ...
TSXV
LI.WT
American Lithium
COIN
BHDUSD
BitcoinHD
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten